Afrocentric Investment (JSE:ACT) Altman Z2-Score: -0.08 (As of Jun. 27, 2026)


JSE:ACT Afrocentric Investment Corp Ltd JSE:ACT
52 GF Score
Price R0.79
GF Value R2.09
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Afrocentric Investment Altman Z2-Score?

Afrocentric Investment JSE:ACT 52 Altman Z2-Score is -0.08 as of Jun. 27, 2026. GuruFocus rates JSE:ACT with a GF Score™ of 52/100 and a GF Value™ of R2.09 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 678 Healthcare Providers & Services companies, Afrocentric Investment ranks worse than 70.65% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Warning Sign:

Afrocentric Investment has a Altman Z2-Score of -0.08, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Afrocentric Investment's Altman Z2-Score or its related term are showing as below:

JSE:ACT' s Altman Z2-Score Range Over the Past 10 Years
Min: -0.08   Med: 3.41   Max: 7.03
Current: -0.08

During the past 13 years, Afrocentric Investment's highest Altman Z2-Score was 7.03. The lowest was -0.08. And the median was 3.41.


Afrocentric Investment  (JSE:ACT) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Afrocentric Investment Altman Z2-Score Related Terms


Afrocentric Investment Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for Afrocentric Investment's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Afrocentric Investment Altman Z2-Score Chart

Afrocentric Investment Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Dec25
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.71 3.32 3.25 3.29 -0.08

Afrocentric Investment Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 3.29 0.00 0.00 -0.08

JSE:ACT vs HCA, THC, DVA: Altman Z2-Score Comparison

For the Medical Care Facilities subindustry, Afrocentric Investment's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Afrocentric Investment Altman Z2-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Afrocentric Investment's Altman Z2-Score falls into.


JSE:ACT
52GF Score
Afrocentric Investment Corp Ltd JSE:ACT
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Afrocentric Investment Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Afrocentric Investment's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.041+3.26*-0.1572+6.72*-0.1092+1.05*0.8504
=-0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2025:
Total Assets was R4,180 Mil.
Total Current Assets was R1,529 Mil.
Total Current Liabilities was R1,357 Mil.
Retained Earnings was R-657 Mil.
Pre-Tax Income was R-532 Mil.
Interest Expense was R-76 Mil.
Total Liabilities was R2,237 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(1528.763 - 1357.163)/4180.454
=0.041

X2=Retained Earnings/Total Assets
=-657.085/4180.454
=-0.1572

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-531.901 - -75.504)/4180.454
=-0.1092

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(1902.784 - 0)/2237.445
=0.8504

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Afrocentric Investment has a Altman Z2-Score of -0.08 indicating it is in Distress Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of -0.08 mean?
Afrocentric Investment (JSE:ACT) has a Altman Z2-Score of -0.08 as of Jun. 27, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Afrocentric Investment and its competitors. According to the industry distribution chart, Afrocentric Investment ranks #479 out of 678 companies in the Healthcare Providers & Services industry, placing it in the top 70.6%.
Is Afrocentric Investment's Altman Z2-Score too high?
Afrocentric Investment's current Altman Z2-Score is -0.08. Based on the distribution chart, Afrocentric Investment ranks #479 out of 678 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Afrocentric Investment has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Afrocentric Investment's Altman Z2-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Afrocentric Investment ranks #479 out of 678 companies for Altman Z2-Score. This places Afrocentric Investment in the lower half of its industry. The industry median Altman Z2-Score is 2.17. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Healthcare Providers & Services company?
The median Altman Z2-Score among Healthcare Providers & Services companies is 2.17, based on 678 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Afrocentric Investment and its competitors. For the Healthcare Providers & Services industry, the median Altman Z2-Score is 2.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Afrocentric Investment's current Altman Z2-Score is -0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Afrocentric Investment stock overvalued right now?
Based on GuruFocus' analysis, Afrocentric Investment (JSE:ACT) is currently considered Possible Value Trap. The stock's GF Value™ is R2.09, compared to a current price of R0.79 — trading 62.2% below its estimated fair value. The current Altman Z2-Score is -0.08. Afrocentric Investment's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Afrocentric Investment (JSE:ACT), the current Altman Z2-Score is -0.08 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Afrocentric Investment (JSE:ACT) Overvalued in 2026?

Based on GuruFocus' analysis, Afrocentric Investment stock appears to be undervalued. The current stock price of R0.79 is trading 62.2% below its estimated GF Value™ of R2.09. GuruFocus considers Afrocentric Investment to be Possible Value Trap.

Key valuation signals for JSE:ACT:

  • Altman Z2-Score: -0.08
  • GF Value™: R2.09 vs. price of R0.79 (62.2% below fair value)
  • GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the JSE:ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Afrocentric Investment Business Description

Address 37 Conrad Road, Florida North, Roodepoort, ZAF, 1709
Afrocentric Investment Corp Ltd is an investment holding company providing specialised services and products to the public and private healthcare sectors. It focuses on making quality healthcare accessible and affordable to members and beneficiaries, with the principal objective of ensuring the delivery of efficient health management services and the distribution of quality products. Its business segments include Healthcare SA, comprising medical scheme administration and health risk management services; Healthcare Retail, comprising pharmaceutical sales and services; Healthcare Africa, comprising healthcare services outside South Africa in Namibia and Mauritius; and IT-related services predominantly within South Africa. It operates across South Africa, Botswana, Mauritius, and Namibia.
52GF Score

Get the complete analysis for JSE:ACT

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R0.79
Price
R2.09
GF Value